Ambulatory blood pressure monitoring in patients with hypertension in COVID-19 pandemic – The Study of European Society of Hypertension (ESH ABPM COVID-19 Study).
Coronavirus disease 2019 (COVID-19) pandemic and the subsequent lockdown profoundly affected almost all aspects of daily life including health services worldwide. The traditional risk factors for increased blood pressure (BP) and hypertension may also demonstrate significant changes during the pandemic.

European Society of Hypertension (ESH), the leading hypertension (HTN) society in Europe, presented an updated position paper on renal denervation (RDN) during the 8th pre-ESH congress satellite symposium in Athens, Greece from September 10-11, 2021 .

This position paper written by an ESH expert Working Group confirms that RDN is considered a safe endovascular procedure without significant short-term or long-term adverse effects based on data available up to three years.

We are very thankful for the continued support of the National Hypertension Societies across Europe and beyond. With their help, the 2021 ESH practice guidelines for office and out-of-office blood pressure measurement have been translated into various languages.

The dissemination of the guidelines is an important goal for ESH. The translation of the guidelines facilitates the diffusion of important information to improve the accuracy of the diagnosis of hypertension and thereby optimize its management.

The goal is to establish a European sustainable and multidisciplinary network of internationally renowned members for blood pressure research in children and adolescents. The initiative conveys 21 countries across Europe and America in a global vision to promote wide networks of excellence in research.

Blood Pressure Calculator. This tool has been developed by the COST Action HyperChildNET as a useful instrument for paediatricians and other clinical professionals working with children and young people.